Relationship between treatment delay and type of reperfusion therapy and mechanical complications of acute myocardial infarction

European Heart Journal: Acute Cardiovascular Care

Volumn 5, Issue 5, 2016, Pages 468-474

  Magalhães, Pedro ^a   Mateus, Pedro ^a   Carvalho, Sofia ^a   Leão, Sílvia ^a   Cordeiro, Filipa ^a   Ilidio Moreira J ^a  

^a Hospital de Vila Real   (Portugal)

Author keywords

Complications; Myocardial infarction; Myocardial reperfusion; Percutaneous coronary intervention; Thrombolytic therapy

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; COMPLICATION; CONSERVATIVE TREATMENT; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; PORTUGAL; PROCEDURES; REGISTER; ST ELEVATION MYOCARDIAL INFARCTION; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION; PERCUTANEOUS CORONARY INTERVENTION; PORTUGAL; REGISTRIES; ST ELEVATION MYOCARDIAL INFARCTION; TIME-TO-TREATMENT;

EID: 85050578335     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872616637038     Document Type: Article

References (28)

1. French JK, Hellkamp AS, Armstrong PW, et al. Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol 2010; 105: 59-63.
2. Poulsen SH, Praestholm M, Munk K, et al. Ventricular septal rupture complicating acute myocardial infarction: clinical characteristics and contemporary outcome. Ann Thorac Surg 2008; 85: 1591-1596.
3. Kutty RS, Jones N and Moorjani N. Mechanical complications of acute myocardial infarction, Cardiol Clin 2013; 31: 519-531.
4. Figueras J, Alcalde O, Barrabés JA, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation 2008; 118: 2783.
5. Viana-Tejedor A, Loughlin G, Fernández-Avilés F, et al. Temporal trends in the use of reperfusion therapy and outcomes in elderly patients with first ST elevation myocardial infarction. Eur Heart J ACC 2015; 4: 461-467.
6. Okino S, Nishiyama K, Ando K, et al. Thrombolysis increases the risk of free wall rupture in patients with acute myocardial infarction undergoing percutaneous coronary intervention. J Interv Cardiol 2005; 18: 167-172.
7. López-Sendón J, Gurfinkel EP, de Sa EL, et al. Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events. Eur Heart J 2010; 31: 1449-1456.
8. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26: 668-674.
9. Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation 2000; 101: 27-32.
10. Gertz SD, Kragel AH, Kalan JM, et al. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators. Am J Cardiol 1990; 66: 904.
11. Mega JL and Morrow DA. ST-elevation myocardial infarction: management. In: Mann DL, Bonow RO, Zipes DP, et al., eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, PA: Elsevier Saunders, 2015, pp. 1095-1154.
12. Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 1996; 27: 1321.
13. Bueno H, Martínez-Sellés M, Pérez-David E, et al. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J 2005; 26: 1705.
14. Moreno R, López-Sendón J, García E, et al. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2002; 39: 598.
15. Santos JF, Aguiar C, Gavina C, et al. Portuguese Registry of Acute Coronary Syndromes: seven years of activity. Rev Port Cardiol 2009; 28: 1465-1500.
16. Portuguese Registry on Acute Coronary Syndromes (ProACS). Available at: https://clinicaltrials.gov/show/ NCT01642329 (accessed 17 February 2016).
17. Portuguese Registry on Acute Coronary Syndromes (ProACS, 2nd phase). Registry Protocol. Available at: http://www.spc.pt/DL/home/listdestaques/Protocolo_RNSCA_2a_Fase_Final.pdf (accessed 17 February 2016).
18. Cheriex EC, de Swart H, Dijkman LW, et al. Myocardial rupture after myocardial infarction is related to the perfusion status of the infarct-related coronary artery. Am Heart J 1995; 129: 644.
19. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
20. Figueras J, Cortadellas J, Calvo F, et al. Relevance of delayed hospital admission on development of cardiac rupture during acute myocardial infarction: study in 225 patients with free wall, septal or papillary muscle rupture. J Am Coll Cardiol 1998; 32: 135.
21. Solodky A, Behar S, Herz I, et al. Comparison of incidence of cardiac rupture among patients with acute myocardial infarction treated by thrombolysis versus percutaneous transluminal coronary angioplasty. Am J Cardiol 2001; 87: 1105-1108.
22. Ohishi F, Hayasaki K and Honda T. Effect of thrombolysis on rupture of the left ventricular free wall following acute myocardial infarction. J Cardiol 1996; 28: 27-32.
23. Patel MR, Meine TJ, Lindblad L, et al. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. Am Heart J 2006; 151: 316.
24. Honan MB, Harrell FE Jr, Reimer KA, et al. Cardiac rupture, mortality and the timing of thrombolytic therapy: a metaanalysis. J Am Coll Cardiol 1990; 16: 359.
25. Becker RC, Charlesworth A, Wilcox RG, et al. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol 1995; 25: 1063.
26. Ruiz-Bailén M, Expósito-Ruiz M, Castillo-Rivera AM, et al. Heart rupture predictors in Spanish myocardial infarction patients: evaluation using propensity score analysis. Med Sci Monit 2010; 16(5): PH49-56.
27. Novak K, Polic S, Capkun V, et al. Free wall rupture (FWR) in patients with acute ST-elevation myocardial infarction (STEMI) receiving fibrinolytic therapy (FT): a 7-year prospective study. Arch Gerontol Geriatr 2012; 54: 266-270.
28. Qian G, Liu HB, Wang JW, et al. Risk of cardiac rupture after acute myocardial infarction is related to a risk of hemorrhage. J Zhejiang Univ Sci B 2013; 14: 736-742